Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02866422 · ClinicalTrials.gov registry record
Development of an Instrument That Monitors Behaviors Associated With OCD
A clinical trial of OCD, sponsored by University of Minnesota.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT02866422: Completed study of OCD, sponsored by University of Minnesota.
NCT02866422 is a study of OCD that has completed, run by University of Minnesota. The registered enrollment target is 40 participants, below the 816-participant average among 18 other OCD trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02866422, a study of OCD, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
To support the discovery of new means for revealing the presence of Obsessive Compulsive Disorder (OCD), facilitating detection through new technology-based metrics, and attempt to automate existing diagnostic procedures allowing for more efficient diagnostic methods that would broaden clinical scope and outreach.
Primary Outcome
Researchers blindly rate the how long (secs) it takes participants to wash their hands.
Conditions Studied
Interventions
- OTHER No Intervention
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-03 |
What the finished NCT02866422 record still lists
NCT02866422 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 816-participant average among 18 other OCD trials with a reported enrollment target (95% lower).
The record links to 1 condition, with OCD appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.
NCT02866422 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02866422 about?
NCT02866422 is a clinical study titled "Development of an Instrument That Monitors Behaviors Associated With OCD". To support the discovery of new means for revealing the presence of Obsessive Compulsive Disorder (OCD), facilitating detection through new technology-based metrics, and attempt to automate existing diagnostic procedures allowing for more efficient diagnostic methods that would broaden clinical scop...
What is the current status of trial NCT02866422?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2014-03. Estimated completion is 2015-03.
What conditions does trial NCT02866422 study?
This clinical trial studies the following conditions: OCD.
What interventions are being tested in trial NCT02866422?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT02866422?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02866422 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for OCD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02866422's enrollment target sits among peer trials
40 14th of 18 higher than 4 of 18 other OCD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other OCD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
RECRUITING
-
Neuromodulation for a Novel OCD Biomarker and Treatment
RECRUITING · NA
-
Open-Label Psilocybin Study in Transdiagnostic Population
RECRUITING · Phase 1
-
Personalized DBS for OCD Guided by Stereoencephalography Mapping
RECRUITING · NA
-
Neurostimulation Versus Therapy for Problems With Emotions
RECRUITING · NA
-
How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia